AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAD8. A total of 28 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $844,000 | -48.7% | 1,000,000 | -50.0% | 0.05% | -55.7% |
| Q3 2019 | $1,645,000 | -40.0% | 2,000,000 | -33.3% | 0.11% | -42.4% |
| Q4 2018 | $2,742,000 | +12.8% | 3,000,000 | +27.4% | 0.18% | +61.4% |
| Q2 2018 | $2,431,000 | -52.9% | 2,355,000 | -52.9% | 0.11% | -55.6% |
| Q1 2018 | $5,165,000 | – | 5,000,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mohican Financial Management, LLC | 1,500,000 | $1,492,000 | 2.87% |
| Telemetry Investments, L.L.C. | 8,000,000 | $7,780,000 | 2.78% |
| Context Capital Management, LLC | 3,500,000 | $3,405,000 | 2.28% |
| Kamunting Street Capital Management, L.P. | 2,500,000 | $2,431,000 | 1.54% |
| BASSO CAPITAL MANAGEMENT, L.P. | 12,205,000 | $11,824,000 | 1.46% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 17,500,000 | $17,269,000 | 1.34% |
| CAMDEN ASSET MANAGEMENT L P /CA | 32,375,000 | $31,485,000 | 1.04% |
| Jabre Capital Partners S.A. | 5,500,000 | $5,328,000 | 1.04% |
| City Financial Investment Co Ltd | 12,500,000 | $12,168,000 | 0.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,250,000 | $15,747,000 | 0.71% |